|
| Literature analysis of clinical study in traditional Chinese Medicine treatment of postsurgical gastroparesis syndrome on digestive system tumors |
| Hits 217 Download times 186 Received:January 28, 2024 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2024.06.12 |
| Key Words
postoperative gastroparesis;digestive system tumor;traditional Chinese medicine;clinical trial;literature analysis |
| Author Name | Affiliation | E-mail | | WANG Zhiyi | Beijing University of Chinese Medicine, Beijing 100029, China
Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Bejing 100078, China | | | LI Quanwang | Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Bejing 100078, China | quanwanqli@126.com | | ZHU Lingfei | Beijing University of Chinese Medicine, Beijing 100029, China | | | LI Bo | Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medcine, Beijing 100010, China | | | ZHOU Qin | Department of Oncology, Dongfang Hospital, Beijing University of Chinese Medicine, Bejing 100078, China | qinzi0424@126.com |
|
| Abstract
|
| [Objective] To evaluate the methodological quality of clinical research on treatment of postsurgical gastroparesis syndrome of digestive system tumors combined with traditional Chinese Medicine （TCM） in recent 10 years，and to analyze the clinical trials characteristics. [Methods] CNKI，Wanfang database，VIP，SinoMed，Pubmed， Web of Science were searched to collect the clinical research literature from January 2013 to December 2022. The methodological quality of the included literature was evaluated by tools as the Cochrane risk of bias assessment tool. The types of studies，diagnostic criteria，interventions and control measures，and outcome measures in the included literature were analyzed. [Results] Totally 31 articles were included，30 were randomized controlled trails and one was retrospective study. The methodological quality of the included Randomized controlled trials（RCTs） was generally low，such as lack of the specific description of randomization protocol，allocation concealment，and blind methods，presence of selective outcome reporting. The diagnostic criteria are not unified，the intervention measures were mainly TCM external treatment，and the clinical efficacy evaluation indicators are not standardized. [Conclusion] Rigorous clinical protocol design should be performed in future studies. It is recommended that researchers should register the study protocol in advance，report the study protocol completely and transparently. The design and implement of the clinical protocol should accordance with international standards. It is expected that relevant guidelines or expert consensus will be issued to unify PGS diagnosis and treatment standards，standardize the judgment criteria of outcome indicators，and carry out research on relevant TCM core indicator set. |
|
|
|
|
|
